Surveys Investigating the Safety Profile of Flibanserin – Importance and Findings
Surveys investigating the safety profile of flibanserin When it comes to assessing the safety profile of any medication, conducting surveys plays a crucial role. This holds true for flibanserin, commonly known as Addyi, a medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal…